汇宇制药,688553,收入构成,报告日期,2021-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),26,6,20,75.62%,0.02% 技术服务,1,0,1,85.24%,0% 国外药品销售,3285,254,3031,92.28%,3.71% 国内药品销售,85217,6530,78687,92.34%,96.27% 汇宇制药,688553,收入构成,报告日期,2021-03-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),12,3,9,75.95%,0.02% 技术服务,1,0,1,85.24%,0% 国外药品销售,1572,123,1449,92.15%,3.75% 国内药品销售,41139,3962,37177,90.37%,96.22% 汇宇制药,688553,收入构成,报告日期,2020-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),655,90,565,86.3%,0.45% 技术服务,190,92,98,51.66%,0.08% 国外药品销售,2758,825,1933,70.07%,1.54% 国内药品销售,132816,10176,122641,92.34%,97.93% 汇宇制药,688553,收入构成,报告日期,2019-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),76,6,69,91.73%,0.11% 技术服务,444,165,280,62.94%,0.42% 国外药品销售,3677,872,2805,76.28%,4.26% 国内药品销售,66510,3786,62724,94.31%,95.21% 汇宇制药,688553,收入构成,报告日期,2018-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),342,106,237,69.13%,5.48% 技术服务,951,229,722,75.91%,16.73% 国外药品销售,1306,484,822,62.92%,19.04% 国内药品销售,2833,297,2536,89.52%,58.75%